DelSiTech at-a-Glance DelSiTech is a technology platform company specializing in long-acting formulations, dedicated to transforming the treatment landscape in the areas of metabolic disease and pain through our lead long-acting injectable assets. DelSiTech’s proprietary Silica Matrix technology platform is highly versatile and has demonstrated compatibility with a wide range of therapeutic agents, including small molecules, peptides, and